Medical Capital Group, LLC (www.medcapadvisors.com) announced today that it is continuing to expand its investment-banking team with the addition of Hari V. Sundram, M.D., a board-certified specialist in anesthesiology and pain medicine.
WALTHAM, Mass. (BusinessWire EON) September 24, 2007 --
Medical Capital Group, LLC (www.medcapadvisors.com)
announced today that it is continuing to expand its investment-banking
team with the addition of Hari V. Sundram, M.D., a
board-certified specialist in anesthesiology and pain medicine.
“We are pleased that Dr. Sundram has joined
Medical Capital Group, and we are looking forward to working with him.
His clinical and medical knowledge will provide our firm’s
clients with the deep knowledge and understanding that they need to
develop exceptional medical devices for the advancement of healthcare
delivery,” said Christopher
J.P. Velis, Chairman and CEO of Medical Capital Group.
Dr. Sundram will serve as Vice President and Medical Director at Medical
Capital Development, working in the business development group and
facilitating the evolution of cutting-edge medical technologies into
growth companies.
Most recently, he has served as a pain specialist at Massachusetts
General Hospital. Dr. Sundram is a member of the Scientific Advisory
Board of Acumen Medical, an early-stage medical device firm developing
catheters for the placement of leads in Bi-Ventricular pacemakers.
Previously, Dr. Sundram co-founded ChemTracker Technologies. Dr. Sundram
holds four device patents and has co-authored eight scientific papers.
He holds a bachelor of science degree from Wayne State University and
graduated from Wayne State University School of Medicine. He also
attended the University of Pennsylvania, the School of Anesthesiology
and Critical Care. Dr. Sundram completed a pain fellowship at
Massachusetts General Hospital/Harvard University.
About Medical Capital Group, LLC
Medical Capital Development partners with engineers, scientists,
doctors, and universities in the development and financing of companies—based
on exceptional medical technologies. The team is comprised of:
experienced entrepreneurs who have founded and run medical technology
companies; physicians with clinical experience; and, financial experts
with investment banking experience specific to the medical technology
sector. Through years of sector-specific medical technology experience,
the Group has developed proprietary insight and contacts in the areas of
clinical, regulatory, design/engineering, intellectual property,
sales/distribution, management, financing, and extensive contacts with
major strategic acquirers.
Trackback URL: http://www.prweb.com/pingpr.php/UHJvZi1DcmFzLUhvcnItTWFnbi1UaGlyLVplcm8=
|
